Aclaris Therapeutics Inc. closed its initial public offering Tuesday, selling a total 5.75 million shares at $11 per share.
The total number of shares sold included an additional 750,000 offered by underwriters to cover overallotments.
Help employers find you! Check out all the jobs and post your resume.
